Quantcast

Latest Prostate Stories

2014-04-23 16:29:46

MARINA DEL REY, Calif., April 23, 2014 /PRNewswire/ -- Join Prostate Oncology Specialists for an educational talk about PROVENGE - a treatment to stimulate the immune system for advanced prostate cancer. Prostate cancer specialist, Dr. Jeffrey Turner, presents and reviews key topics: Why PROVENGE might be right for me? How do I know the PROVENGE treatment is working?How is PROVENGE different from hormone or chemotherapy?Does PROVENGE affect my PSA?How does PROVENGE boost my immune...

2014-04-18 13:44:32

The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. An analysis of prostate tissue biopsies collected from some participants of the placebo arm of the Prostate Cancer Prevention...

2014-04-15 08:28:19

Phase III Trial Now Recruiting Patients SANTA ROSA, Calif., April 15, 2014 /PRNewswire/ -- A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now recruiting participants to study the effects of dietary supplement PectaSol-C® modified citrus pectin (MCP) in controlling prostate specific antigen (PSA) levels in prostate cancer patients. "MCP has shown activity against prostate and other cancers in a number of previous studies, and toxicology...

2014-04-11 08:24:36

SAN DIEGO, April 11, 2014 /PRNewswire/ -- GenomeDx Biosciences announced today that two study abstracts for the company's genomic tests for prostate and bladder cancers have been selected as "Best Posters in a Poster Session" by conference organizers at the 29(th) Annual European Association of Urology Congress. The first poster presentation demonstrates the clinical validation of the Decipher® prostate cancer classifier for predicting treatment failure in men treated with...

2014-04-08 12:30:37

-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStat(TM) prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States. An initial pilot study to be launched in April will examine 300 patient samples and is...

New Prostate Cancer Test May Remove The Need For Painful Biopsies
2014-04-08 09:00:53

April Flowers for redOrbit.com - Your Universe Online Globally, over one million men a year have prostate tissue samples taken to check for signs of prostate cancer. This procedure can involve up to 12 large biopsy needles and has been called barbaric by Mayo Graduate School of Medicine Professor Matthew Gettman. As well, it reveals that 70 percent of the men undergoing the procedure do not have cancer. Beyond being unnecessarily painful and risky for the patient, the procedure is...

2014-04-08 04:22:15

2014: The Year of Innovation in Men's Health, According to New York Urology Specialists NEW YORK, April 8, 2014 /PRNewswire/ -- Men have lower life expectancy than women. This discrepancy is especially pronounced for African American men who live 6 fewer years than women. According to the CDC, life expectancy in the US is 76 years for men compared to 81 for women. http://photos.prnewswire.com/prnvar/20140408/NY00250LOGO Over the past 25 years, care for diseases that affect women...

2014-04-07 12:47:39

A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). Professor Robert Bristow will tell the conference that although surgery and precision radiotherapy are the mainstays of treatment for cancer that is confined to the prostate, the cancer...

2014-04-03 12:29:05

WASHINGTON, April 3, 2014 /PRNewswire-USNewswire/ -- ZERO - The End of Prostate Cancer has been selected as one of 2014 Best Nonprofits to work for by The NonProfit Times' annual survey. ZERO ranked 44 in a group of top-tier nonprofits nationwide. http://photos.prnewswire.com/prnvar/20130129/DC50244LOGO "We're honored to be recognized as one of the top 50 best nonprofits to work for in the U.S.," said ZERO's CEO Jamie Bearse. "This great distinction is reflected in the dedication...

2014-04-02 23:00:36

The segment will follow a man suffering from BPH, and his wife through their struggles with his enlarged prostate, how he found relief through an in-office procedure, and the quality of life improvements they have experienced since he had the procedure. Minneapolis, MN (PRWEB) April 02, 2014 Urologix, Inc. (OTCQB:ULGX) the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced that it will be featured on the televised series In View,...


Latest Prostate Reference Libraries

Prostate
2013-03-04 15:21:55

The male prostate gland acts as an exocrine gland in the male reproductive system. It is a firm, partly muscular, chestnut sized gland near the neck of the urethra in males. Formation and Orientation The prostate is usually formed within the ninth week of the embryonic stage in reproductive development. The prostate can be separated into either “lobes” or “zones”. When looking at a prostate divided into zones, there are four distinct regions. The first zone is the Peripheral...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related